What's new

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 66, Status: Authorised

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 66, Status: Authorised

May 2, 2025 - 11:29
 0
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 66, Status: Authorised
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 66, Status: Authorised
Read More

Tags:

Previous Article

New sensory experiences for increasingly addictive cosmetics

Next Article

LVMH’s Moët Hennessy to cut workforce by 10%

Related Posts

Human medicines European public assessment report (EPAR): Junod, denosumab, Status: Opinion

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0

Human medicines European public assessment report (EPAR): Alprolix, eftrenonacog alfa, Date of authorisation: 12/05/2016, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

May 2, 2025  0

Minutes of the CAT meeting 19-21 March 2025

Apr 28, 2025  0